Company profile: Atacor
1.1 - Company Overview
Company description
- Provider of extravascular cardiac lead systems enabling defibrillation, bradycardia pacing, and anti-tachycardia pacing without contacting the heart or vascular system, including the AtaCor EV-ICD Lead System and the EV Temporary Pacing Lead System that provides pacing support via a parasternal approach.
Products and services
- AtaCor EV Temporary Pacing Lead System: Delivers pacing support using a parasternal implantation approach that avoids cardiac and vascular entry, enabling short‑term rhythm stabilization without intravascular placement
- AtaCor EV-ICD Lead System: Enables extravascular defibrillation plus bradycardia and anti‑tachycardia pacing without contacting the heart or vascular system for comprehensive rhythm correction
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Atacor
TandemLife
HQ: United States
Website
- Description: Provider of innovative medical device products for cardiologists and cardiac surgeons worldwide, delivering unique solutions for patients requiring circulatory support, including the FDA-cleared TandemHeart System that provides extracorporeal circulatory support in minutes.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full TandemLife company profile →
Vitatron
HQ: The Netherlands
Website
- Description: Provider of pacemakers—implanted devices that deliver timed electrical discharges to regulate slow or irregular heart rhythms—and the Vitatron 2090 Programmer, used to program and support advanced Vitatron cardiac devices to meet patient-specific needs.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Vitatron company profile →
Vidacare
HQ: United States
Website
- Description: Provider of intraosseous access devices for diagnostic, monitoring, and therapeutic applications. Develops, manufactures, and markets the EZ-IO Product System, designed to provide controlled vascular access through the intraosseous route.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Vidacare company profile →
Prevencio
HQ: United States
Website
- Description: Provider of multi-proteomic cardiovascular blood tests: HART CVE uses a machine learning algorithm to predict 1-year risk of heart attack, stroke, or cardiac death; HART CADhs detects obstructive coronary artery disease; HART PAD diagnoses obstructive peripheral artery disease; HART AS diagnoses and monitors aortic valve stenosis (98% exclusion accuracy); HART Amputation Risk assesses amputation risk (87% accuracy).
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Prevencio company profile →
Volcano
HQ: United States
Website
- Description: Provider of medical device technologies that make imaging and therapy simpler, more informative and less invasive, offering a suite of analytical tools that use sound as a guiding element to deliver more meaningful information for physicians worldwide.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Volcano company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Atacor
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Atacor
2.2 - Growth funds investing in similar companies to Atacor
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Atacor
4.2 - Public trading comparable groups for Atacor
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →